Eli Lilly and Company (LLY) vs Visa Inc. (V)
See how Eli Lilly and Company and Visa Inc. differ across market data and performance, so you can decide which asset best fits your strategy.
$1,156.73
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full Page$379.37
NYSE
Visa Inc. is the world’s largest payment processor. In fiscal 2025, the company handled nearly $17 trillion in total payment volume. Visa operates in more than 200 countries and territories and processes transactions in over 160 currencies. Its network is capable of handling more than 65,000 transactions per second.
View Full PageKey Metrics Comparison
Eli Lilly and CompanyLLY
Market Cap$1.032T
Price$1,156.73
24h Change-1.52%
24h Volume$3.03M
Employees50,000
Shares Outstanding944,818,881
Visa Inc.V
Market Cap$708.302B
Price$379.37
24h Change-0.58%
24h Volume$6.72M
Employees34,100
Shares Outstanding1,659,709,932
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
LLY
59.3%V
40.7%Volume Share
Share of combined 24h volume
LLY
31.0%V
69.0%24h Performance
Price change over last 24 hours
LLY
-1.52%V
-0.58%Price Comparison
Eli Lilly and Company
Visa Inc.